Please note…

You are now on the ey.com India site. To return to the ey.com United States site or other country site, click on the India (English) link on the upper right of this page, and select your preferred country site.

x
Skip to main navigation

Pharmaceuticals advisory services, biotechnology, Pharma sector consulting - Ernst & Young - India

Life sciences: the pulse of innovation

Opportunities for growth in life sciences come from Pharma 3.0, health issues facing an increasingly aging global population and a recent push for health care reform. Our knowledge can help position your company as a leader in these diverse and changing markets. Are you ready to grow?

Our global reach

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential, whether you work in the area of biotechnology, pharmacology or medical technology.

Improving execution

We bring together a worldwide team with deep technical experience in providing assurance, tax, transaction and advisory services to the industry’s leaders

Biotechnology

Biotechnology

Biotech companies are delivering new levels of health, prosperity and sustainability across the world.

Pharmaceutical

Pharmaceutical

Key drivers are reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and evolving customer needs.

Medical Technology

Medical technology

Fundamental drivers in the global healthcare economy suggest demand for medical technology products should be robust for years to come.

Life Sciences

XBRL services  

Our XBRL services

XBRL promises to web-enable the financial reporting process for both preparers and consumers. And we make the transition easy for you.

Stethoscope on Counter

Top 11 trends in data privacy for 2011

The growing reliance on technology could expose the health care industry to new threats. Read our insights. 

Register now for Webcast

Progressions 2011: Building Pharma 3.0
A transformation of the pharmaceutical industry is underway as companies begin shifting from producing new medicines to demonstrating improved health outcomes. No longer the dominant health care player, pharma has a new focus. We report on pharma’s progress in creating new business models and partnerships focused on technology and sustainability.

Six global trends shaping the business world

How will pharma develop in 2011 and beyond? From the growing power of emerging markets to rapid innovations in technology, see which global trends and drivers are likely to shape the future of your business.

Subscribe to our publications

Subscribe to our thought leadership publications, newsletters and reports for information and insight on industry trends.

Back to top